The pharma major announced that its fund raising committee approved to raise funds through non-convertible debentures (NCDs) and commercial papers (CP) aggregating to Rs 10,000 crore in one or more tranches.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
